Co-Diagnostics (CODX) vs NeuroOne Medical Technologies (NMTC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
NeuroOne Medical Technologies is the larger company by market cap ($9.8 million vs $7.6 million), about 1.3 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CODX | NMTC |
|---|---|---|
| Share price | $1.09 | $1.08 |
| Market cap | $7.61M | $9.83M |
| 1-day change | -2.68% | -2.70% |
| YTD return | — | -76.25% |
| 1-year return | — | -82.69% |
| 5-year return | — | -94.00% |
| EPS (TTM) | $-26.14 | $-0.99 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $46.50 | $6.42 |
| 52-week low | $0.906 | $0.962 |
| Distance from 52-week high | -97.66% | -83.18% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +266.97% | +573.15% |
| Average volume | 326.53K | 339.60K |
| Shares outstanding | 6.98M | 9.11M |
| Employees | 115 | 18 |
| Sector | Healthcare | Healthcare |
| Industry | Medical Devices | Medical Devices |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Co-Diagnostics
CODX stock →Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally.
Healthcare · Medical Devices · 115 employees
About NeuroOne Medical Technologies
NMTC stock →NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States. The company also provides solutions for spinal cord stimulation, brain stimulation, drug delivery and ablation solutions for patients suffering from epilepsy, trigeminal neuralgia, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other pain-related neurological disorders.
Healthcare · Medical Devices · 18 employees
CODX vs NMTC FAQ
Which is bigger, Co-Diagnostics or NeuroOne Medical Technologies?
NeuroOne Medical Technologies (NMTC) is larger, with a market capitalization of $9.83M compared with $7.61M for Co-Diagnostics (CODX).
Are Co-Diagnostics and NeuroOne Medical Technologies in the same industry?
Yes. Both are classified in the Medical Devices industry within the Healthcare sector.